1. Home
  2. SMWB vs DAWN Comparison

SMWB vs DAWN Comparison

Compare SMWB & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMWB
  • DAWN
  • Stock Information
  • Founded
  • SMWB 2007
  • DAWN 2018
  • Country
  • SMWB Israel
  • DAWN United States
  • Employees
  • SMWB N/A
  • DAWN N/A
  • Industry
  • SMWB Computer Software: Programming Data Processing
  • DAWN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMWB Technology
  • DAWN Health Care
  • Exchange
  • SMWB Nasdaq
  • DAWN Nasdaq
  • Market Cap
  • SMWB 654.9M
  • DAWN 658.9M
  • IPO Year
  • SMWB 2021
  • DAWN 2021
  • Fundamental
  • Price
  • SMWB $8.28
  • DAWN $7.02
  • Analyst Decision
  • SMWB Strong Buy
  • DAWN Strong Buy
  • Analyst Count
  • SMWB 8
  • DAWN 7
  • Target Price
  • SMWB $15.75
  • DAWN $31.57
  • AVG Volume (30 Days)
  • SMWB 525.3K
  • DAWN 1.3M
  • Earning Date
  • SMWB 08-05-2025
  • DAWN 07-29-2025
  • Dividend Yield
  • SMWB N/A
  • DAWN N/A
  • EPS Growth
  • SMWB N/A
  • DAWN N/A
  • EPS
  • SMWB N/A
  • DAWN N/A
  • Revenue
  • SMWB $258,017,999.00
  • DAWN $161,922,000.00
  • Revenue This Year
  • SMWB $16.87
  • DAWN $17.98
  • Revenue Next Year
  • SMWB $14.96
  • DAWN $49.50
  • P/E Ratio
  • SMWB N/A
  • DAWN N/A
  • Revenue Growth
  • SMWB 15.06
  • DAWN N/A
  • 52 Week Low
  • SMWB $5.71
  • DAWN $6.08
  • 52 Week High
  • SMWB $17.64
  • DAWN $16.76
  • Technical
  • Relative Strength Index (RSI)
  • SMWB 53.68
  • DAWN 58.34
  • Support Level
  • SMWB $8.53
  • DAWN $6.52
  • Resistance Level
  • SMWB $9.19
  • DAWN $7.24
  • Average True Range (ATR)
  • SMWB 0.44
  • DAWN 0.26
  • MACD
  • SMWB 0.06
  • DAWN 0.07
  • Stochastic Oscillator
  • SMWB 56.84
  • DAWN 78.37

About SMWB Similarweb Ltd.

Similarweb Ltd provides digital data and analytics that power critical business decisions. The group recognizes revenue from subscriptions to the platform and other subscription products on a straight-line basis over the term of the contract subscription period beginning on the date access to the platform is granted, provided all other revenue recognition criteria have been met. It has geographic presence in Israel, the United States, the United Kingdom, Asia Pacific, Europe, and Other. The group generates the majority of its revenue from the United States.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: